(for every order > 35€)
Description
An indispensible update on available antithrombotic medications
Venous thromboembolic disease is most frequently diagnosed after a patient has an initial episode of phlebitis or a pulmonary embolism. Treatment is aimed at preventing the clot from spreading in the vein and from migrating to the lungs.
The mainstay of treatment is daily injection of an anticoagulant (heparin) with the rapid addition of an oral anticoagulant (antivitamin K drug or VKA), whose effects are less immediate.
While these treatments have proven their efficacy over the past 50 years, they have also shown their limitations, particularly in terms of the risks they have for patients taking them long term.
The management of venous thrombosis has undergone massive changes in the past few years with the advent of new molecules. These new treatments are also considered to be appropriate for more vulnerable patient populations, for example, patients with cardiac rhythm disorders.
These new treatment strategies are addressed by today's leading specialists in the pages of this book. It is an indispensible guide for cardiologists and haematologists both.